Some visit links earn us a commission.
Quick verdict
Henry Meds is the better pick for most patients on overall scoring. Henry built the cash-pay compounded GLP-1 category and still runs the cleanest version of it. Predictable bundled pricing and true month-to-month terms, though the semaglutide tiers moved behind signup in June 2026. Pivoted hard after the FDA shortage delisting and now leans on personalization-claim 503A pharmacies.
That said, Calibrate wins on specific dimensions. Calibrate is a coaching and insurance-navigation program whose value proposition has weakened as direct-to-consumer pricing from Lilly and Novo undercut the 'we'll handle insurance for you' pitch. Cut its fee from $299 to $199 in 2026.
Side-by-side
| Calibrate | Henry Meds | |
|---|---|---|
| Starts from | $224/mo (incl. medication) | $297/mo (incl. medication) |
| Monthly cost gap | Henry Meds is $45/mo cheaper than Calibrate | |
| Lock-in | 3-mo minimum | Month-to-month |
| Time to prescription | 14 days | 2 days |
| Consultation type | Live | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Calibrate | Henry Meds | |
|---|---|---|
| Pricing transparency | 5/10 | 8/10 |
| Cancellation terms | 6/10 | 9/10 |
| Onboarding experience | 4/10 | 8/10 |
| Medication options | 7/10 | 6/10 |
| Member reviews | 9.2/10 | 9/10 |
When to choose Calibrate
Best for committed behavioral coaching
Patients who specifically want behavioral coaching and have insurance that covers branded GLP-1s. Calibrate's clinicians and coaches handle prior authorization paperwork well.
Calibrate wins on medication options, member reviews on the dimensional scoring. The caveat: Cash-pay patients. With $597 upfront plus $199/mo plus medication separate, the all-in is rarely under $400/mo. Direct LillyDirect or NovoCare paths beat this on price. Note also: Restructured in 2024 amid demand declines
When to choose Henry Meds
Best for cheapest compounded
Buyers who want predictable flat-rate compounded semaglutide with no commitments and minimal friction.
Henry Meds wins on pricing transparency, cancellation terms, onboarding experience and runs $45/mo cheaper than Calibrate at the entry tier ($179 vs $224). Over a year that's $540 you keep. The caveat: Patients who want branded Wegovy or Zepbound through insurance, or who want a high-touch coaching program. Note also: Subject of ongoing scrutiny over personalization-claim compounding post-shortage delisting (FDA Feb 2025).
If cost is your main filter
Henry Meds is the cheaper monthly: $179 all-in vs $224 for Calibrate. That's $45 a month or $540a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $135 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Calibrate (3-mo minimum) and Henry Meds (month-to-month) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Henry Meds's easier cancellation is the safer trial.
FAQ
Is Calibrate cheaper than Henry Meds?
Can I switch from Calibrate to Henry Meds mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
